Rothschild & Co Asset Management US’s Acadia Pharmaceuticals ACAD Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2018 Q2	–	Sell	-26,289	Closed	-$591K	–	372
2018 Q1	$591K	Buy	+26,289	New	+$591K	0.01%	347